These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 14186547)
1. PITFALLS IN THE THROMBOLYTIC TREATMENT OF VENOUS OCCLUSION. AMERY A; VERMYLEN J; MAES H; VERSTRAETE M Vasc Dis; 1964 Mar; 1():89-93. PubMed ID: 14186547 [No Abstract] [Full Text] [Related]
2. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS. HECKER SP Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527 [TBL] [Abstract][Full Text] [Related]
3. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. FLETCHER AP; ALKJAERSIG N; SHERRY S; GENTON E; HIRSH J; BACHMANN F J Lab Clin Med; 1965 May; 65():713-31. PubMed ID: 14281368 [No Abstract] [Full Text] [Related]
4. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE). JAMES DC; BROWSE NL Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065 [No Abstract] [Full Text] [Related]
5. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
6. RECENT THERAPEUTIC ASPECTS OF THROMBOLYSIS. SCHMUTZLER R Sangre (Barc); 1964; 41():375-6. PubMed ID: 14248821 [No Abstract] [Full Text] [Related]
7. [THROMBOPHLEBITIS AND PHLEBOTHROMBOSIS --PATHOGENESIS, CLINICAL PICTURE AND THERAPY]. LINKE H Z Arztl Fortbild (Jena); 1963 Nov; 57():1221-30. PubMed ID: 14116144 [No Abstract] [Full Text] [Related]
9. ORAL ADMINISTRATION OF A FIBRINOLYSIN IN VASCULAR INFLAMMATION AND OCCLUSION. VARGA LK; MITCHELL JP; MCGAVACK TH Nebr State Med J; 1964 Feb; 49():53-60. PubMed ID: 14117291 [No Abstract] [Full Text] [Related]
10. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS]. SANTOSTORIBIO F Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889 [No Abstract] [Full Text] [Related]
11. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)]. GIBELLI A Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688 [No Abstract] [Full Text] [Related]
12. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
13. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
14. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT. COON WW Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774 [No Abstract] [Full Text] [Related]
15. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763 [No Abstract] [Full Text] [Related]
16. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
17. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
18. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. LIEBERMAN J Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772 [TBL] [Abstract][Full Text] [Related]
19. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]